Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other Non-Current Assets: 2011-2025

Historic Other Non-Current Assets for Gyre Therapeutics (GYRE) over the last 13 years, with Sep 2025 value amounting to $5.3 million.

  • Gyre Therapeutics' Other Non-Current Assets rose 92.41% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 92.41%. This contributed to the annual value of $6.3 million for FY2024, which is 531.16% up from last year.
  • Per Gyre Therapeutics' latest filing, its Other Non-Current Assets stood at $5.3 million for Q3 2025, which was down 0.26% from $5.3 million recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Other Non-Current Assets registered a high of $6.3 million during Q4 2024, and its lowest value of $168,000 during Q2 2022.
  • Its 3-year average for Other Non-Current Assets is $2.6 million, with a median of $1.3 million in 2024.
  • Per our database at Business Quant, Gyre Therapeutics' Other Non-Current Assets crashed by 85.63% in 2022 and then spiked by 1,546.43% in 2024.
  • Quarterly analysis of 5 years shows Gyre Therapeutics' Other Non-Current Assets stood at $472,000 in 2021, then skyrocketed by 619.07% to $3.4 million in 2022, then plummeted by 70.68% to $995,000 in 2023, then skyrocketed by 531.16% to $6.3 million in 2024, then spiked by 92.41% to $5.3 million in 2025.
  • Its Other Non-Current Assets was $5.3 million in Q3 2025, compared to $5.3 million in Q2 2025 and $5.6 million in Q1 2025.